All News

The landscape for treating CLL is changing, bringing about questions and hope for a cure.

The FDA's breakthrough designation is meant to expedite the development of therapies that offer substantial benefits over existing options.

As the number of HNC survivors continues to increase, the American Cancer Society issued new guidelines for patients and their physicians.

The “sugar is poison” ideology is wrong.

Life after cancer calls for yet another new normal.

In the midst of the approval of new treatments for colorectal cancer, Alan P. Venook wants to remind health care professionals not to forget the more traditional and established therapies.

Pain from chemotherapy-induced peripheral neuropathy may be able to be reduced using neurofeedback, according to a recent study.

CURE speaks with Joyce O’Shaughnessy, MD, on the rise of treatment options for patients with estrogen receptor (ER)-positive metastatic breast cancer.

Looking for the silver lining during cancer isn't always easy, but it is possible.

Several new tests for prostate cancer are on the market. When used alongside PSA screenings, they can provide a much more straightforward insight into prostate cancer risk.

According to a recent study, financial distress can affect a newly diagnosed patient's overall well-being and quality of life.

Long before we departed on our vacation, a pact was made. The island was declared a cancer-free zone.

A recent study showed that women being treated for gynecologic malignancies can reduce their need for opioids by receiving Exparel.

Sometimes rational thinking isn't my strong suit.

Our bodies are fragile, but that doesn't mean we are not strong.